Prosecution Insights
Last updated: October 04, 2026

Kagan Binder, Pllc - Abbott Laboratories - Csi

Technology area: Medical Devices & Mechanical Engineering

8 pending office actions • 1 client • 7 examiners • 2 art units • 0 of 8 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Analysis

Kagan Binder, PLLC - Abbott Laboratories - CSI operates in Medical Devices & Mechanical Engineering. It has 2672 career applications. The firm has a resolved allowance rate of 81.43 percent. It averages 3.78 office actions per allowance. There are 8 pending office actions.

The 81.43 percent allowance rate is derived from 2672 career applications. The average of 3.78 office actions per allowance reflects the prosecution effort required in the medical device sector. The 8 pending office actions represent the firm's current workload.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=2672 apps, methodology: how we score firms)

81.4%
Allowance Rate
n=2672
+0.63σ
Allowance Rate (norm)
n=2672
3.8
OAs to Allowance
n=1434
+0.04σ
OAs to Allow (norm)
n=1434
1130 days
Time to Allowance
n=1434
+13.7pp
Interview Lift
n=2672
29.3%
RCE Rate
n=2672
2.4%
Appeal Rate
n=2672

Rejection Performance (% of received rejections ultimately overcome)

72.1%
§101 Overcome
n=129
74.4%
§102 Overcome
n=630
77.4%
§103 Overcome
n=1076
77.8%
§112 Overcome
n=896

Specialization & Scale

A61K, A61B, G01N
Top CPC Subclasses
10%
Top-3 CPC Share
n=2672
10
Practitioners
n=2672
267.2
Apps / Practitioner
n=2672

Portfolio Summary

8
Total Pending OAs
2
Non-Final OAs
6
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (1)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (25%)
6
Medium (75%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only6 (75%)
Multi-statute (no §101)2 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
8
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
POLAND, CHERIE MICHELLE 2 59.5% +33.3%
LOUIS, RICHARD G 1 74.7% +17.2%
NGUYEN, TUAN VAN 1 81.7% +19.5%
TANNER, JOCELIN C 1 72.2% +34.8%
DANG, PHONG SON H 1 78.0% +24.6%
HOLLM, JONATHAN ADAM 1 50.4% +53.3%
DARB, HAMZA A. 1 74.4% +30.9%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18906647 REDUCER FOR CRITICAL LIMB ISCHEMIA AND CRITICAL HAND ISCHEMIA TANNER, JOCELIN C 35d overdue
19120110 INTRAVASCULAR LITHOTRIPSY DEVICES AND SYSTEMS SYSTEM WITH FORWARD FACING ELECTRODES AND FLEX CIRCUIT ARRANGEMENTS NGUYEN, TUAN VAN —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18906647 REDUCER FOR CRITICAL LIMB ISCHEMIA AND CRITICAL HAND ISCHEMIA TANNER, JOCELIN C 35d overdue
17938490 ROTATIONAL DRIVE SHAFTS AND INTRAVASCULAR MEDICAL DEVICES THEREOF POLAND, CHERIE MICHELLE 20d
18866415 MANAGEMENT OF STORED ANGULAR MOMENTUM IN STALLED INTRAVASCULAR ROTATIONAL DRIVE SHAFTS FOR ATHERECTOMY POLAND, CHERIE MICHELLE 35d
19129816 INTRAVASCULAR LITHOTRIPSY DEVICES WITH THIN-WALLED BALLOONS AND SYSTEMS LOUIS, RICHARD G —
19120110 INTRAVASCULAR LITHOTRIPSY DEVICES AND SYSTEMS SYSTEM WITH FORWARD FACING ELECTRODES AND FLEX CIRCUIT ARRANGEMENTS NGUYEN, TUAN VAN —
18632431 ROTATIONAL SYSTEMS COMPRISING A POLYMER DRIVESHAFT DANG, PHONG SON H —
18393260 INTRAVASCULAR LITHOTRIPSY DEVICES AND SYSTEMS HAVING SPARK MONITORING FEEDBACK HOLLM, JONATHAN ADAM —
17809668 GUIDE EXTENSION CATHETERS DARB, HAMZA A. —

Client Portfolio (1 client)

Client (Assignee)Pending OAs
Cardiovascular Systems 8

Top Art Units

Art UnitApps
37717
37831

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19129816 INTRAVASCULAR LITHOTRIPSY DEVICES WITH THIN-WALLED BALLOONS AND SYSTEMS Cardiovascular Systems, Inc. LOUIS, RICHARD G 3771 §103 Non-Final OA — Pending May 14, 2025
19120110 INTRAVASCULAR LITHOTRIPSY DEVICES AND SYSTEMS SYSTEM WITH FORWARD FACING ELECTRODES AND FLEX CIRCUIT ARRANGEMENTS Cardiovascular Systems, Inc. NGUYEN, TUAN VAN 3771 §102§103§112 Non-Final OA — Pending Apr 10, 2025
18866415 MANAGEMENT OF STORED ANGULAR MOMENTUM IN STALLED INTRAVASCULAR ROTATIONAL DRIVE SHAFTS FOR ATHERECTOMY Cardiovascular Systems, Inc. POLAND, CHERIE MICHELLE 3771 §103 Final Rejection 35d Pending Nov 15, 2024
18906647 REDUCER FOR CRITICAL LIMB ISCHEMIA AND CRITICAL HAND ISCHEMIA Cardiovascular Systems, Inc. TANNER, JOCELIN C 3771 §102§103 Final Rejection 35d overdue Pending Oct 04, 2024
18632431 ROTATIONAL SYSTEMS COMPRISING A POLYMER DRIVESHAFT Cardiovascular Systems, Inc. DANG, PHONG SON H 3771 §103 Final Rejection — Pending Apr 11, 2024
18393260 INTRAVASCULAR LITHOTRIPSY DEVICES AND SYSTEMS HAVING SPARK MONITORING FEEDBACK Cardiovascular Systems, Inc. HOLLM, JONATHAN ADAM 3771 §103 Final Rejection — Pending Dec 21, 2023
17938490 ROTATIONAL DRIVE SHAFTS AND INTRAVASCULAR MEDICAL DEVICES THEREOF Cardiovascular Systems, Inc. POLAND, CHERIE MICHELLE 3771 §103 Final Rejection 20d Pending Oct 06, 2022
17809668 GUIDE EXTENSION CATHETERS Cardiovascular Systems, Inc. DARB, HAMZA A. 3783 §103 Final Rejection — Pending Jun 29, 2022

Managing Kagan Binder, Pllc - Abbott Laboratories - Csi's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month